Catalyst Wire Dossier Catalyst Wire Dossier

GILENYA

FINGOLIMOD HCL · Novartis Pharmaceuticals Corporation
Drug timelines are a Plus or Pro feature.

73 regulatory and trial events tracked for GILENYA, covering 2010-09-21 to 2026-07-30. Get the full timeline:

Most recent: EMA Authorised: Gilenya (fingolimod hydrochloride) — Novartis Europharm Limited

See pricing